Here are the top stories to read during Wednesday's trading: ...

New York Post may receive revenue from affiliate and advertising partnerships for sharing this content and/or when you make a purchase. If you’ve been feeling a little low in more than one aspect of ...

Our USA TODAY Network food writers love sharing their picks for the top local spots, from best steakhouses to favorite dive bars. But none of those lists compares to our popular Restaurants of the ...

The neuroscientist, health guru, and controversial podcaster Andrew Huberman just revealed something that has his fans fuming — but also not all that surprised. During a nearly three-hour interview ...

Share on Pinterest Country music star Jelly Roll revealed that Testosterone Replacement Therapy played a key role in his weight-loss journey. Image credit: Matt Jelonek/Getty Images Jelly Roll says ...

Everyday Health independently vets all recommended products. If you purchase a featured product, we may be compensated. Learn why you can trust us. Everyday Health independently vets all recommended ...

View post: Hitting Plateaus? Why Trainers Say You Might Need to 'Periodize Recovery' for Stressful Seasons and Heavy Training Blocks If you pay even a little attention to the health and wellness space ...

Share on Pinterest An FDA panel has called for an easing of restrictions on testosterone replacement therapy (TRT). Image Credit: Malorny/Getty Images A Food and Drug Administration (FDA) expert panel ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Pacific Elm Properties has owned ...

An office tower in Dallas’ Arts District has a new, local owner. An affiliate of TRT Holdings purchased St. Paul Place, a 22-story office building at 750 North Saint Paul Street, from Pacific Elm ...

At an FDA discussion of testosterone replacement therapy, a top official called for special health centers to address a “men’s health crisis.” Others called to ease men’s access to hormones. The US ...

A Food and Drug Administration panel on Wednesday advocated for regulatory changes that would make testosterone medications more widely accessible, including removing their classification as ...